Advanced-stage CD30-positive mycosis fungoides: Clinical experience with brentuximab vedotin

被引：0
|
作者：
Vico-Alonso, Cristina [1 ]
Jose Andres-Lencina, Juan [1 ]
Aragon-Miguel, Raquel [1 ]
Calleja-Algarra, Alba [1 ]
Pinilla-Martin, Belen [1 ]
Sanchez-Velazquez, Alba [1 ]
Munoz-Gonzalez, Hector [1 ]
Penalba, Maria [1 ]
Velasco Tamariz, Virginia [1 ]
Postigo LLorente, Concepcion [2 ]
Ortiz-Romero, Pablo L.
机构：
[1] Hosp Univ 12 Octubre, Madrid, Spain
[2] Hosp Univ 12 Octubre, Dept Dermatol, Madrid, Spain
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2020年 / 83卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
16223
引用
收藏
页码：AB173 / AB173
页数：1
相关论文
共 50 条
  • [41] Brentuximab Vedotin (SGN-35), an antibody-drug conjugate for the treatment of CD30-positive malignancies
    Gualberto, Antonio
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (02) : 205 - 216
  • [42] CD30-Positive Cutaneous T-Cell Lymphoma and Response to Brentuximab Vedotin: 2 Illustrative Cases
    Mody, Kabir
    Wallace, Jill S.
    Stearns, Diane M.
    Bowers, George
    Lacy, Shannon R.
    Levy, Norman B.
    Zug, Kathryn A.
    Lansigan, Frederick
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (03): : 319 - 323
  • [43] Primary Cutaneous CD30-Positive Lymphoproliferative Disorders-Current Therapeutic Approaches with a Focus on Brentuximab Vedotin
    Stein, Tomasz
    Robak, Tadeusz
    Biernat, Wojciech
    Robak, Ewa
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (03)
  • [44] Complete remission in CD30-positive refractory extranodal NK/T-cell lymphoma with brentuximab vedotin
    Kim, Hee Kyung
    Moon, Seong Mi
    Moon, Ji Hoon
    Park, Jee Eun
    Byeon, Seonggyu
    Kim, Won Seog
    BLOOD RESEARCH, 2015, 50 (04) : 254 - 256
  • [45] Brentuximab vedotin therapy for CD30-positive cutaneous T-cell lymphoma: a targeted approach to management
    Scarisbrick, Julia J.
    FUTURE ONCOLOGY, 2017, 13 (27) : 2405 - 2411
  • [46] Mycosis fungoides with CD30-positive large-cell transformation clinically mimicking scarring alopecia
    Bidier, Mona
    Pushkarevskaya, Anna
    Enk, Alexander
    Hartmann, Martin
    Toberer, Ferdinand
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 (10): : 1021 - 1023
  • [47] Regression of CD30-positive large cell transformation arising on patch lesion of early mycosis fungoides
    Kubo, Naoko
    Itoh, Munenari
    Watanabe, Yoshinori
    Nobeyama, Yoshimasa
    Asahina, Akihiko
    CLINICAL CASE REPORTS, 2020, 8 (12): : 2418 - 2422
  • [48] BRENTUXIMAB VEDOTIN AS SINGLE AGENT IN REFRACTORY OR RELAPSED CD30-POSITIVE HODGKIN LYMPHOMA: THE FRENCH NAME PATIENT PROGRAM EXPERIENCE IN 241 PATIENTS
    Perrot, A.
    Monjanel, H.
    Bouabdallah, R.
    Cartron, G.
    Salles, G.
    Bernard, M.
    Tilly, H.
    Borel, C.
    Bouabdallah, K.
    Sebban, C.
    Morshhauser, F.
    Brice, P.
    HAEMATOLOGICA, 2014, 99 : 498 - 498
  • [49] Brentuximab Vedotin as Single Agent in Refractory or Relapsed CD30-Positive Hodgkin Lymphoma: the French Name Patient Program Experience in 241 Patients
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2014, 12 (08) : 4 - 5
  • [50] Complete Remission of a CD30-positive large-cell anaplastic Lymphoma under Therapy with Brentuximab Vedotin (Adcetris®)
    Drescher, C.
    Mickler, M.
    Berneburg, M.
    Haferkamp, S.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 17 - 17
12345